TOP HEADLINES

Featured Story

Fresenius Kabi receives FDA approval of three-chamber bag for parenteral nutrition

Fresenius Kabi announced Aug. 26 that it has received approval of the Kabiven and Perikabiven, parenteral nutrition products in a three-chamber bag.

New antibody-drug conjugate research partnership announced

AB SCIEX and Dalton Pharma Services announced that they are joining forces on R&D of Antibody-Drug Conjugate analysis capabilities.

Organic nanoparticles offer 'complete package' against cancer: delivery and imaging

Nanoparticles come in many shapes and sizes, each specifically designed to play a precise role in cancer treatment. And now, researchers from UC Davis have created nanotechnology with the ability to perform multiple tasks and the ultimate goal of destroying tumors.

Vascular device drug delivery company surpasses VC goal

Advanced Catheter Therapies' venture capital funding round has been oversubscribed, reflecting investor interest in the company's Occlusion Perfusion Catheter for localized drug delivery in the peripheral vasculature.

PharmaJet secures FDA approval for jet injection system for flu vaccine

The FDA has approved the first needle-free delivery system for the inactivated flu vaccine. The jet injector, made by Pennsylvania-based PharmaJet, has been shown to successfully provide vaccination without a needle jab, which could ultimately help improve vaccination rates.

MORE NEWS

From Our Sister Sites

FierceMedicalDevices

A novel biomarker could make it easier for physicians to diagnose rheumatoid arthritis early, thereby improving patients' prospects. The best results come when conventional antibody testing is combined with the new biomarker.

FiercePharma Manufacturing

The big deal in contract manufacturing these days is biologics. Patheon is among those investing in facilities to capture more of that business. Patheon parent DPx has agreed to buy Gallus BioPharmaceuticals, presenting Patheon with its first biologics plants in the U.S.